(SWKS) Skyworks Solutions - Overview
Stock: Amplifiers, Filters, Front-End Modules, Switches, Power Isolators
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.11% |
| Yield on Cost 5y | 1.77% |
| Yield CAGR 5y | 7.39% |
| Payout Consistency | 27.9% |
| Payout Ratio | 48.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 39.3% |
| Relative Tail Risk | -11.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.11 |
| Alpha | -49.31 |
| Character TTM | |
|---|---|
| Beta | 1.690 |
| Beta Downside | 1.527 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.20% |
| CAGR/Max DD | -0.30 |
Description: SWKS Skyworks Solutions January 04, 2026
Skyworks Solutions Inc. (NASDAQ:SWKS) designs, manufactures, and markets a broad portfolio of analog and mixed-signal semiconductor components-including amplifiers, antenna tuners, DC/DC converters, and front-end modules-serving end-markets such as smartphones, automotive, aerospace, and industrial IoT across North America, Asia, and Europe. The company distributes its products via a direct sales force, electronic component distributors, and independent representatives.
As of FY 2023, Skyworks reported revenue of roughly $3.7 billion with an operating margin near 22 %, reflecting strong pricing power in high-growth 5G handset and automotive radar segments. The firm’s exposure to the accelerating rollout of 5G infrastructure and the shift toward electric and autonomous vehicles is a key economic driver, while ongoing global semiconductor supply-chain constraints remain a material risk to its ability to meet demand. (Assumption: FY 2023 figures are based on the latest publicly filed earnings release; any subsequent quarter could materially alter these metrics.)
For a deeper quantitative breakdown of Skyworks valuation metrics, the ValueRay platform offers a concise, data-driven view worth checking out.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 394.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA -0.94 > 1.0 |
| NWC/Revenue: 40.00% < 20% (prev 70.81%; Δ -30.81% < -1%) |
| CFO/TA 0.17 > 3% & CFO 1.32b > Net Income 394.3m |
| Net Debt (-572.4m) to EBITDA (937.1m): -0.61 < 3 |
| Current Ratio: 2.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (150.5m) vs 12m ago -6.75% < -2% |
| Gross Margin: 41.13% > 18% (prev 0.41%; Δ 4072 % > 0.5%) |
| Asset Turnover: 50.05% > 50% (prev 48.55%; Δ 1.50% > 0%) |
| Interest Coverage Ratio: 17.77 > 6 (EBITDA TTM 937.1m / Interest Expense TTM 26.6m) |
Altman Z'' 6.90
| A: 0.21 (Total Current Assets 2.73b - Total Current Liabilities 1.11b) / Total Assets 7.87b |
| B: 0.72 (Retained Earnings 5.63b / Total Assets 7.87b) |
| C: 0.06 (EBIT TTM 472.7m / Avg Total Assets 8.10b) |
| D: 2.68 (Book Value of Equity 5.66b / Total Liabilities 2.11b) |
| Altman-Z'' Score: 6.90 = AAA |
Beneish M -3.22
| DSRI: 0.76 (Receivables 398.4m/520.0m, Revenue 4.05b/4.04b) |
| GMI: 1.00 (GM 41.13% / 40.93%) |
| AQI: 1.21 (AQ_t 0.50 / AQ_t-1 0.41) |
| SGI: 1.00 (Revenue 4.05b / 4.04b) |
| TATA: -0.12 (NI 394.3m - CFO 1.32b) / TA 7.87b) |
| Beneish M-Score: -3.22 (Cap -4..+1) = AA |
What is the price of SWKS shares?
Over the past week, the price has changed by +9.27%, over one month by +2.37%, over three months by -9.11% and over the past year by +0.08%.
Is SWKS a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 21
- Sell: 3
- StrongSell: 1
What are the forecasts/targets for the SWKS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 71.5 | 15.1% |
| Analysts Target Price | 71.5 | 15.1% |
| ValueRay Target Price | 58.2 | -6.2% |
SWKS Fundamental Data Overview February 08, 2026
P/E Forward = 12.9366
P/S = 2.3036
P/B = 1.5361
P/EG = 1.0351
Revenue TTM = 4.05b USD
EBIT TTM = 472.7m USD
EBITDA TTM = 937.1m USD
Long Term Debt = 496.4m USD (from longTermDebt, last fiscal year)
Short Term Debt = 499.6m USD (from shortTermDebt, last quarter)
Debt = 996.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -572.4m USD (from netDebt column, last quarter)
Enterprise Value = 8.77b USD (9.34b + Debt 996.2m - CCE 1.57b)
Interest Coverage Ratio = 17.77 (Ebit TTM 472.7m / Interest Expense TTM 26.6m)
EV/FCF = 8.03x (Enterprise Value 8.77b / FCF TTM 1.09b)
FCF Yield = 12.46% (FCF TTM 1.09b / Enterprise Value 8.77b)
FCF Margin = 26.95% (FCF TTM 1.09b / Revenue TTM 4.05b)
Net Margin = 9.73% (Net Income TTM 394.3m / Revenue TTM 4.05b)
Gross Margin = 41.13% ((Revenue TTM 4.05b - Cost of Revenue TTM 2.39b) / Revenue TTM)
Gross Margin QoQ = 41.26% (prev 40.67%)
Tobins Q-Ratio = 1.11 (Enterprise Value 8.77b / Total Assets 7.87b)
Interest Expense / Debt = 0.63% (Interest Expense 6.30m / Debt 996.2m)
Taxrate = 27.80% (30.5m / 109.7m)
NOPAT = 341.3m (EBIT 472.7m * (1 - 27.80%))
Current Ratio = 2.46 (Total Current Assets 2.73b / Total Current Liabilities 1.11b)
Debt / Equity = 0.17 (Debt 996.2m / totalStockholderEquity, last quarter 5.76b)
Debt / EBITDA = -0.61 (Net Debt -572.4m / EBITDA 937.1m)
Debt / FCF = -0.52 (Net Debt -572.4m / FCF TTM 1.09b)
Total Stockholder Equity = 5.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.87% (Net Income 394.3m / Total Assets 7.87b)
RoE = 6.83% (Net Income TTM 394.3m / Total Stockholder Equity 5.78b)
RoCE = 7.53% (EBIT 472.7m / Capital Employed (Equity 5.78b + L.T.Debt 496.4m))
RoIC = 5.03% (NOPAT 341.3m / Invested Capital 6.78b)
WACC = 11.01% (E(9.34b)/V(10.33b) * Re(12.14%) + D(996.2m)/V(10.33b) * Rd(0.63%) * (1-Tc(0.28)))
Discount Rate = 12.14% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.32%
[DCF Debug] Terminal Value 68.72% ; FCFF base≈1.15b ; Y1≈1.20b ; Y5≈1.39b
Fair Price DCF = 105.0 (EV 15.22b - Net Debt -572.4m = Equity 15.79b / Shares 150.4m; r=11.01% [WACC]; 5y FCF grow 4.88% → 2.90% )
EPS Correlation: -72.80 | EPS CAGR: -13.30% | SUE: 1.19 | # QB: 4
Revenue Correlation: -76.81 | Revenue CAGR: -6.56% | SUE: 1.59 | # QB: 3
EPS next Quarter (2026-03-31): EPS=1.04 | Chg30d=+0.089 | Revisions Net=+2 | Analysts=22
EPS current Year (2026-09-30): EPS=4.68 | Chg30d=+0.264 | Revisions Net=+0 | Growth EPS=-21.1% | Growth Revenue=-8.0%
EPS next Year (2027-09-30): EPS=5.00 | Chg30d=-0.039 | Revisions Net=+5 | Growth EPS=+6.7% | Growth Revenue=+3.4%